United Therapeutics

United Therapeutics

Yahoo Finance • 21 days ago

A Look At United Therapeutics (UTHR) Valuation After Strong Long Term Shareholder Returns

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. United Therapeutics overview United Therapeutics (UTHR) has drawn... Full story

Yahoo Finance • 22 days ago

Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors.

The State Street Health Care Select Sector SPDR ETF(NYSEMKT:XLV) provides low-cost, passive exposure to established healthcare giants, while the Simplify Health Care ETF (NYSEMKT:PINK) offers an active strategy targeting medical breakthrou... Full story

Yahoo Finance • 23 days ago

Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics

[Supreme Court of the United States. Washington DC, USA.] Mindaugas Dulinskas The Supreme Court unanimously sided with generic drugmaker Hikma (HKMPF [https://seekingalpha.com/symbol/HKMPF]) and against Amarin Corp. (AMRN [https://seeking... Full story

Yahoo Finance • 28 days ago

What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year

Key Points Krensavage bought 241,245 Ultragenyx Pharmaceutical shares last quarter. The quarter-end position value increased by $4.75 million, reflecting both trading and share price changes. The trade represented a roughly 2% increase in... Full story

Yahoo Finance • 28 days ago

United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock

We just covered the 12 Best Stocks to Invest In According to Jim Simons’ Renaissance Technologies and United Therapeutics Corporation (NASDAQ:UTHR) ranks 1st on this list. United Therapeutics Corporation (NASDAQ:UTHR) is a long-term holdi... Full story

Yahoo Finance • last month

JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms

Investing.com -- JPMorgan has reinstated ratings and price targets on 14 large-cap biotechnology companies, describing the sector as being at a critical “inflection point” as pipeline successes increasingly translate into profitable commer... Full story

Yahoo Finance • last month

5 Insightful Analyst Questions From United Therapeutics’s Q1 Earnings Call

United Therapeutics' first quarter results fell below Wall Street's revenue and earnings expectations, but the market responded favorably. Management attributed the shortfall mainly to seasonality and operational disruptions, including sev... Full story

Yahoo Finance • 2 months ago

Oracle upgraded, Planet Fitness downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Wells Fargo upgraded United Therapeutic... Full story

Yahoo Finance • 2 months ago

Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcoa, Chiron Real Estate, Clear Secure, Fortinet, Fresh Pet, Kennametal, Oracle, PayPal, United Therapeutics, and More

Quick Read: Risk assets soared higher on Wednesday on reports of a potential peace deal with Iran. Stocks, bonds, and precious metals all saw strong buying, as the major indices once again touched record highs. Investors should be careful... Full story

Yahoo Finance • 2 months ago

Bernard Horn's Strategic Moves: Eastman Chemical Co Leads the Way with 1.28% Portfolio Impact

This article first appeared on GuruFocus. Insights from Bernard Horn (Trades, Portfolio)'s First Quarter 2026 N-PORT Filing Warning! GuruFocus has detected 9 Warning Signs with XKRX:005930. Is XKRX:005930 fairly valued? Test your thesis... Full story

Yahoo Finance • 2 months ago

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Regeneron (NASDAQ:REGN) and the best and worst performers in the biotechnology ind... Full story

Yahoo Finance • 2 months ago

Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV). Over the next few years, therap... Full story

Yahoo Finance • 2 months ago

How The MannKind (MNKD) Story Is Shifting With Tyvaso DPI And Soft Mist Uncertainty

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. MannKind’s fair value estimate has been trimmed from US$7.50 to ab... Full story

Yahoo Finance • 2 months ago

3 Reasons Investors Love United Therapeutics (UTHR)

Since April 2021, the S&P 500 has delivered a total return of 68.6%. But one standout stock has more than doubled the market - over the past five years, United Therapeutics has surged 186% to $583.82 per share. Its momentum hasn’t stopped... Full story

Yahoo Finance • 2 months ago

Truist Securities Touts MannKind Corporation (MNKD) Prospects on Tyvaso Franchise Development

MannKind Corporation (NASDAQ:MNKD) is one of the best healthcare penny stocks to buy according to hedge funds. On March 30, Truist Securities reiterated that MannKind (NASDAQ:MNKD) is a Buy with a $7 price target in response to positive tr... Full story

Yahoo Finance • 3 months ago

United Therapeutics price target raised to $519 from $471 at Morgan Stanley

Morgan Stanley analyst Terence Flynn raised the firm’s price target on United Therapeutics (UTHR) to $519 from $471 and keeps an Equal Weight rating on the shares. The firm adjusted models among its biopharma coverage for IQVIA trends as w... Full story

Yahoo Finance • 3 months ago

Nike downgraded, IBM initiated: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Mizuho upgraded Shake Shack(SHAK) to O... Full story

Yahoo Finance • 3 months ago

US Stock Market Today S&P 500 Futures Rise On Fed Caution And Bond Jitters

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The Morning Bull - US Market Morning Update Tuesday, Mar, 31 2026 US stock futures are pointing higher this morning,... Full story

Yahoo Finance • 3 months ago

Stocks Pressured by Economic Fallout from Iran War

The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.39%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.11%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.78%.  June E-mini S&P futures (ESM26) fell -0.43%, and June... Full story

Yahoo Finance • 3 months ago

Sector Update: Health Care Stocks Higher Late Afternoon

Health care stocks rose late Monday afternoon, with the NYSE Health Care Index increasing 0.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story